−0.04 CAD
−1.29 M CAD
0.00 CAD
10.56 M
About ME Therapeutics Holdings, Inc.
Sector
Industry
CEO
Salim Zulifkar Dhanji
Website
Headquarters
Vancouver
Founded
2021
ISIN
CA5527671054
FIGI
BBG01JPMCSS6
ME Therapeutics Holdings, Inc. provides biotechnology and pharmaceutical services. It engages in research and development of cancer fighting drugs in the field of immuno-oncology (IO). ME Therapeutics Holdings develops drug candidates that can increase the efficacy of current IO drugs by targeting suppressive myeloid cells which are known to hinder the effectiveness of current IO treatments. The company was founded on November 9, 2021 and is headquartered in Vancouver, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of METX is 4.00 CAD — it hasn't changed in the past 24 hours. Watch ME Therapeutics Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange ME Therapeutics Holdings, Inc. stocks are traded under the ticker METX.
METX stock has fallen by −20.00% compared to the previous week, the last month showed zero change in price, over the last year ME Therapeutics Holdings, Inc. has showed a −11.11% decrease.
METX reached its all-time high on Mar 19, 2025 with the price of 11.00 CAD, and its all-time low was 0.05 CAD and was reached on Nov 29, 2023. View more price dynamics on METX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
METX stock is 0.00% volatile and has beta coefficient of 1.64. Track ME Therapeutics Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is ME Therapeutics Holdings, Inc. there?
Yes, you can track ME Therapeutics Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
METX net income for the last quarter is −353.45 K CAD, while the quarter before that showed −199.98 K CAD of net income which accounts for −76.74% change. Track more ME Therapeutics Holdings, Inc. financial stats to get the full picture.
No, METX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, METX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ME Therapeutics Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ME Therapeutics Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ME Therapeutics Holdings, Inc. stock shows the sell signal. See more of ME Therapeutics Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.